Literature DB >> 23507359

Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia.

Cynthia Z Burton1, Lea Vella, Philip D Harvey, Thomas L Patterson, Robert K Heaton, Elizabeth W Twamley.   

Abstract

BACKGROUND: The MATRICS Consensus Cognitive Battery (MCCB) and proposed co-primary measures are gaining momentum as outcome measures in clinical trials, highlighting the need to evaluate their psychometric properties. The MCCB composite score has been proposed to be the optimal primary outcome measure, though its validity is unknown. This study aimed to evaluate the factor structure of the MCCB in a schizophrenia sample and determine whether its cognitive domains are separable.
METHODS: 183 outpatients with schizophrenia or schizoaffective disorder completed a comprehensive test battery. Confirmatory factor analysis was used to test the factor structure of the MCCB; hierarchical regression then examined the relative contribution of individual cognitive variables to predict the MCCB factor scores. Finally, the relationships between the resulting factors and two performance-based measures of functional capacity were explored.
RESULTS: A three-factor MCCB model representing processing speed, attention/working memory, and learning fits the data well and was an improvement over a unifactorial model. Symbol coding, spatial span, and visual learning were the most robust predictors for each of the three factors; symbol coding proved to be the best single predictor of overall cognitive performance. The three factors were also significantly related to a performance-based measure of everyday functioning but not a performance-based measure of social skills.
CONCLUSIONS: These analyses suggest that the six MCCB "domains" as constructed can be collapsed into fewer domains composed of multiple item scores; they also support the notion that impaired processing speed is a fundamental cognitive deficit in schizophrenia and that MCCB performance is related to functional capacity. Cognition and functional capacity measures require more research to determine if they differ. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23507359      PMCID: PMC3740948          DOI: 10.1016/j.schres.2013.02.026

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  31 in total

1.  Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.

Authors:  Michael F Green; Keith H Nuechterlein; Robert S Kern; Lyle E Baade; Wayne S Fenton; James M Gold; Richard S E Keefe; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

2.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

3.  Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Authors:  Richard S E Keefe; Robert M Bilder; Philip D Harvey; Sonia M Davis; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; Del D Miller; Jose M Canive; Lawrence W Adler; Theo C Manschreck; Marvin Swartz; Robert Rosenheck; Diana O Perkins; Trina M Walker; T Scott Stroup; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2006-04-19       Impact factor: 7.853

4.  Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.

Authors:  Dwight Dickinson; Mary E Ramsey; James M Gold
Journal:  Arch Gen Psychiatry       Date:  2007-05

5.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Authors:  Dwight Dickinson; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-08-09       Impact factor: 9.306

6.  General and specific cognitive deficits in schizophrenia: Goliath defeats David?

Authors:  Dwight Dickinson; J Daniel Ragland; James M Gold; Ruben C Gur
Journal:  Biol Psychiatry       Date:  2008-05-09       Impact factor: 13.382

7.  Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.

Authors:  Christopher R Bowie; Abraham Reichenberg; Thomas L Patterson; Robert K Heaton; Philip D Harvey
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

8.  Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden.

Authors:  Philip D Harvey; Lars Helldin; Christopher R Bowie; Robert K Heaton; Anna-Karin Olsson; Fredrik Hjärthag; Torsten Norlander; Thomas L Patterson
Journal:  Am J Psychiatry       Date:  2009-06-01       Impact factor: 18.112

9.  Evidence of factorial variance of the Mayer-Salovey-Caruso Emotional Intelligence Test across schizophrenia and normative samples.

Authors:  Shaun M Eack; Michael F Pogue-Geile; Catherine G Greeno; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2009-06-06       Impact factor: 4.939

10.  Development of a brief scale of everyday functioning in persons with serious mental illness.

Authors:  Brent T Mausbach; Phillip D Harvey; Sherry R Goldman; Dilip V Jeste; Thomas L Patterson
Journal:  Schizophr Bull       Date:  2007-03-06       Impact factor: 9.306

View more
  21 in total

1.  Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief.

Authors:  Lea Vella; Thomas L Patterson; Philip D Harvey; Margaret McNamara McClure; Brent T Mausbach; Michael J Taylor; Elizabeth W Twamley
Journal:  Psychiatry Res       Date:  2017-06-12       Impact factor: 3.222

2.  Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.

Authors:  Richard S E Keefe; Vicki G Davis; Nathan B Spagnola; Dana Hilt; Nancy Dgetluck; Stacy Ruse; Thomas D Patterson; Meera Narasimhan; Philip D Harvey
Journal:  Eur Neuropsychopharmacol       Date:  2014-06-28       Impact factor: 4.600

3.  Faux pas recognition performance in a help-seeking population at clinical high risk of psychosis.

Authors:  TianHong Zhang; ZhengHui Yi; HuiJun Li; HuiRu Cui; YingYing Tang; Xi Lu; LiHua Xu; ZhenYing Qian; YiKang Zhu; LiJuan Jiang; Annabelle Chow; ChunBo Li; KaiDa Jiang; ZePing Xiao; JiJun Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-19       Impact factor: 5.270

4.  Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia.

Authors:  Bruno Biagianti; Melissa Fisher; Benjamin Brandrett; Danielle Schlosser; Rachel Loewy; Mor Nahum; Sophia Vinogradov
Journal:  Schizophr Res       Date:  2019-02-04       Impact factor: 4.939

5.  Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.

Authors:  William S Stone; Raquelle I Mesholam-Gately; Anthony J Giuliano; Kristen A Woodberry; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert W McCarley; Robert Heinssen; Michael F Green; Keith Nuechterlein; Larry J Seidman
Journal:  Schizophr Res       Date:  2016-02-16       Impact factor: 4.939

Review 6.  Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.

Authors:  Frederick C Nucifora; Edgar Woznica; Brian J Lee; Nicola Cascella; Akira Sawa
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

7.  In search of multimodal neuroimaging biomarkers of cognitive deficits in schizophrenia.

Authors:  Jing Sui; Godfrey D Pearlson; Yuhui Du; Qingbao Yu; Thomas R Jones; Jiayu Chen; Tianzi Jiang; Juan Bustillo; Vince D Calhoun
Journal:  Biol Psychiatry       Date:  2015-02-24       Impact factor: 13.382

8.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

9.  Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).

Authors:  A McCleery; M F Green; G S Hellemann; L E Baade; J M Gold; R S E Keefe; R S Kern; R I Mesholam-Gately; L J Seidman; K L Subotnik; J Ventura; K H Nuechterlein
Journal:  Psychol Med       Date:  2015-04-28       Impact factor: 7.723

10.  Lower- and Higher-Level Social Cognitive Factors Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls: Relationship With Neurocognition and Functional Outcome.

Authors:  Lindsay D Oliver; John D Haltigan; James M Gold; George Foussias; Pamela DeRosse; Robert W Buchanan; Anil K Malhotra; Aristotle N Voineskos
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.